InvestorsHub Logo
Followers 2
Posts 34
Boards Moderated 1
Alias Born 07/14/2015

Re: TERIA post# 156

Sunday, 02/21/2016 5:02:11 AM

Sunday, February 21, 2016 5:02:11 AM

Post# of 291
Strategy on opioid abuse
Stephen Doberstein Senior Vice President and Chief Scientific Officer from Nektar Therapeutics will be chairing the 16th annual Pain Therapeutics conference in May! Engineering brain entry rate to reduce opioid abuse indicating that Nektar are on the cusp of some major developments in Pain drugs. Pain Therapeutics
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NKTR News